본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

R&D Achievement

Print

Patent

GCMS through various practical patent applications and registration in order to announce the results that are recognized overseas and continue to present excellent research results.
We are doing our best.

Patent
Applied Products Patent Abstract Registration No.
GENEDIA Quantum COVID-19 Ag
A method for preparing nanoparticles having hydrophilic ligands
and antibodies conjugated to each surface there by improving
the efficiency and reproducibility of a production process.
(KR)102298773
GCare LIPID, GREENCARE LIPID
An apparatus for measuring cholesterol, which comprises :
improve reliability on the measurement value, prevent a
separate check strip from being lost, and cause no need to
separately store a check strip.
(KR)102140768
The present invention relates to a strip for measuring blood
lipids. The strip for measuring blood lipids, thereby having an
effect of increasing measurement result accuracy of the
biological sample.
(KR)101898786
(US)11408901B2
(EP)3561511B1
(CN)ZL201780086975.2
GREENCARE A1c
The measuring method of the glucosylated hemoglobin rate.
Using this method the error of amount of the used reagent and
sample blood are less and the measurement result is exact.
(KR)102398283
(US)11226344 B2
The use is convenient detachable cassette for glycated
hemoglobin measurement with improved accuracy by
sequential leakage of reagents through rotation.
(KR)102403319
GENEDIA Multi Influenza Ag
The kit for detecting multi-influenza using the monoclonal
antibodies in accordance with the present invention can
detect influenza A type, B type, and subtypes of H1, H3, and
H5 at the same time, there by being useful for rapid and sensitive
field detection and diagnosis of the influenza.
(KR)101587645
(US)10488414 B2
GENEDIA Influenza A/B Ag2,
GREENCARE Flu 2 Influenza A&B Ag
The present invention relateds to a monoclonal antibody specific
to influenza A virus and a method for treating and diagnosing
influenza infection using the same and, more particularly to a
monoclonal antibody specific to homogglutinin(HA) of the
influenza A virus and a method.
(KR)101628331
GENEDIA Avellino
The use of invention can diagnose Avellino corneal dystrophy
more promptly and accurately compared with the existing
method for diagnosing Avellino corneal dystrophy, and can
also determine the suitabililty of nucleic acids which are used
in an accurate determination and test.
(KR)101577109